382 related articles for article (PubMed ID: 34305893)
1. The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy.
Liu G; Liu M; Wang J; Mou Y; Che H
Front Immunol; 2021; 12():660974. PubMed ID: 34305893
[TBL] [Abstract][Full Text] [Related]
2. Epicutaneous immunotherapy induces gastrointestinal LAP
Tordesillas L; Mondoulet L; Blazquez AB; Benhamou PH; Sampson HA; Berin MC
J Allergy Clin Immunol; 2017 Jan; 139(1):189-201.e4. PubMed ID: 27417020
[TBL] [Abstract][Full Text] [Related]
3. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
Front Immunol; 2018; 9():1951. PubMed ID: 30233572
[TBL] [Abstract][Full Text] [Related]
4. The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.
Lanser BJ; Leung DYM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):153-161. PubMed ID: 29081025
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Treatment of Food Allergy: Sublingual and Epicutaneous Immunotherapy.
Sindher S; Fleischer DM; Spergel JM
Immunol Allergy Clin North Am; 2016 Feb; 36(1):39-54. PubMed ID: 26617226
[TBL] [Abstract][Full Text] [Related]
6. Sublingual and Patch Immunotherapy for Food Allergy.
Waldron J; Kim EH
Immunol Allergy Clin North Am; 2020 Feb; 40(1):135-148. PubMed ID: 31761114
[TBL] [Abstract][Full Text] [Related]
7. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.
Dioszeghy V; Mondoulet L; Dhelft V; Ligouis M; Puteaux E; Dupont C; Benhamou PH
Clin Exp Allergy; 2014 Jun; 44(6):867-81. PubMed ID: 24666588
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of epicutaneous immunotherapy for food allergy.
Wang J; Sampson HA
Pediatr Allergy Immunol; 2018 Jun; 29(4):341-349. PubMed ID: 29369411
[TBL] [Abstract][Full Text] [Related]
9. Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.
Dioszeghy V; Mondoulet L; Puteaux E; Dhelft V; Ligouis M; Plaquet C; Dupont C; Benhamou PH
Cell Mol Immunol; 2017 Sep; 14(9):770-782. PubMed ID: 27063469
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for Food Allergy: Are We There Yet?
Gernez Y; Nowak-Węgrzyn A
J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
[TBL] [Abstract][Full Text] [Related]
11. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.
Mondoulet L; Dioszeghy V; Puteaux E; Ligouis M; Dhelft V; Plaquet C; Dupont C; Benhamou PH
J Allergy Clin Immunol; 2015 Jun; 135(6):1546-57.e4. PubMed ID: 25583102
[TBL] [Abstract][Full Text] [Related]
12. Interventional Therapies for the Treatment of Food Allergy.
Parrish CP; Kim EH; Bird JA
Immunol Allergy Clin North Am; 2018 Feb; 38(1):77-88. PubMed ID: 29132676
[TBL] [Abstract][Full Text] [Related]
13. Epicutaneous immunotherapy: the next step for food allergy desensitization.
De Jong NW
Expert Rev Clin Immunol; 2018 Dec; 14(12):977-978. PubMed ID: 30295101
[No Abstract] [Full Text] [Related]
14. Therapeutic perspectives in food allergy.
Marcucci F; Isidori C; Argentiero A; Neglia C; Esposito S
J Transl Med; 2020 Aug; 18(1):302. PubMed ID: 32758254
[TBL] [Abstract][Full Text] [Related]
15. Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice.
Mondoulet L; Dioszeghy V; Busato F; Plaquet C; Dhelft V; Bethune K; Leclere L; Daviaud C; Ligouis M; Sampson H; Dupont C; Tost J
Allergy; 2019 Jan; 74(1):152-164. PubMed ID: 29779209
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Allergen-Specific Immunotherapy Induces Tolerance in a Murine Model of Shrimp Allergy.
Leung NYH; Wai CYY; Shu SA; Chang CC; Chu KH; Leung PSC
Int Arch Allergy Immunol; 2017; 174(2):86-96. PubMed ID: 29065408
[TBL] [Abstract][Full Text] [Related]
17. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
Mondoulet L; Dioszeghy V; Ligouis M; Dhelft V; Dupont C; Benhamou PH
Clin Exp Allergy; 2010 Apr; 40(4):659-67. PubMed ID: 20002446
[TBL] [Abstract][Full Text] [Related]
18. Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets.
Laoubi L; Lacoffrette M; Valsesia S; Lenief V; Guironnet-Paquet A; Mosnier A; Dubois G; Cartier A; Monti L; Marvel J; Espinosa E; Malissen B; Henri S; Mondoulet L; Sampson HA; Nosbaum A; Nicolas JF; Dioszeghy V; Vocanson M
J Allergy Clin Immunol; 2022 Nov; 150(5):1194-1208. PubMed ID: 35779666
[TBL] [Abstract][Full Text] [Related]
19. Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
Kumar MNK; Zhou C; Wu MX
J Control Release; 2016 Aug; 235():82-90. PubMed ID: 27235977
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
Parrish CP; Har D; Andrew Bird J
Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
